Title

Tocopherols and the Treatment of Colon Cancer

Document Type

Conference Proceeding

Publication Date

1-1-2004

Description

Colorectal cancer is the second most common cause of cancer deaths in the United States. Vitamin E (VE) and other antioxidants may help prevent colon cancer by decreasing the formation of mutagens arising from the free radical oxidation of fecal lipids or by "non-antioxidant" mechanisms. VE is not a single molecule, but refers to at least eight different molecules, that is, four tocopherols and four tocotrienols. Methods: Both animal models and human colon cancer cell lines were used to evaluate the chemopreventive potential of different forms of VE. Rats were fed diets deficient in tocopherols or supplemented with either α-tocopherol or γ-tocopherol. Half the rats in each of these groups received normal levels of dietary Fe and the other half Fe at eight times the normal level. In our cell experiments, we looked at the role of γ-tocopherol in upregulating peroxisome proliferator-activated receptor-γ (PPAR-γ) in the SW 480 human cell line. Results: Rats fed the diets supplemented with α-tocopherol had higher levels of VE in feces, colonocytes, plasma, and liver than did rats fed diets supplemented with γ-tocopherol. Dietary Fe levels did not influence tocopherol levels in plasma, liver, or feces. For colonocytes, high dietary Fe decreased tocopherol levels. Rats fed the γ-tocopherol-supplemented diets had lower levels of fecal lipid hydroperoxides than rats fed the α-tocopherol-supplemented diets. Ras-p21 levels were significantly lower in rats fed the γ-tocopherol-supplemented diets compared with rats fed the α-tocopherol-supplemented diets. High levels of dietary Fe were found to promote oxidative stress in feces and colonocytes. Our data with the SW480 cells suggest that both α- and γ-tocopherol upregulate PPAR-γ mRNA and protein expression, γ-tocopherol was, however, found to be a better enhancer of PPAR-γ expression than α-tocopherol at the concentrations tested.

COinS